
### [NCIT:C27510](http://purl.obolibrary.org/obo/NCIT_C27510)
**Label:** Kaposiform Hemangioendothelioma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 53.40%
- [NCIT:C53416](http://purl.obolibrary.org/obo/NCIT_C53416) (Rarely Metastasizing Lesion) 52.78%
- [NCIT:C53415](http://purl.obolibrary.org/obo/NCIT_C53415) (Locally Aggressive Lesion) 52.78%
- [NCIT:C51134](http://purl.obolibrary.org/obo/NCIT_C51134) (Capillary Sized Vascular Channel Formation) 52.78%
- [NCIT:C49113](http://purl.obolibrary.org/obo/NCIT_C49113) (Slit-Like Vascular Channel Formation) 52.78%
- [NCIT:C36186](http://purl.obolibrary.org/obo/NCIT_C36186) (Globular Hyaline Body) 52.78%
- [NCIT:C36129](http://purl.obolibrary.org/obo/NCIT_C36129) (High Grade Lesion) 52.78%
- [NCIT:C35990](http://purl.obolibrary.org/obo/NCIT_C35990) (Hemosiderin Deposition) 52.78%
- [NCIT:C35380](http://purl.obolibrary.org/obo/NCIT_C35380) (Hemorrhagic Change) 52.78%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) 38.13%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and (not ([NCIT:C39152](http://purl.obolibrary.org/obo/NCIT_C39152) (Hepatocyte Growth Factor Receptor Signaling Pathway BioCarta))) 38.13%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and (not ([NCIT:C39147](http://purl.obolibrary.org/obo/NCIT_C39147) (Calpain-2 Cell Motility Pathway))) 38.13%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and (not ([NCIT:C39146](http://purl.obolibrary.org/obo/NCIT_C39146) (MAPKinase Signaling Pathway))) 38.13%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and (not ([NCIT:C39141](http://purl.obolibrary.org/obo/NCIT_C39141) (Longevity Pathway))) 38.13%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and (not ([NCIT:C39135](http://purl.obolibrary.org/obo/NCIT_C39135) (Keratinocyte Differentiation Pathway))) 38.13%


